الفهرس 
Title : Evaluation of Albumin-Bilirubin (ALBI) score in detection of early mortality post living donor Liver Transplantation
ContantsOnly 14 pages are availabe for public view
 |  | from | 158 |  |  |
| | | from | 158 | | |
Abstract
Background &Aim: The Albumin Bilirubin (ALBI) is a novel but simple model score that was firstly introduced to predict long-term survival in patients with Hepatocellular carcinoma (HCC). It has been recently introduced to evaluate post liver transplantation (LT) outcome where it successfully predicted post-LT complications and survival in patients with living donor liver transplantation (LDLT). This study aimed to assess the predictive ability of ALBI scoring system in detection of short term (6 months) clinical outcome of LDLT, in terms of morbidities and mortality. Patients Material/Methods: This was a retrospective study that was conducted on patients who underwent LDLT at LT unit Al-Manial Specialized Hospital. ALBI score and grades were measured for all patients then correlated with morbidities and mortality post LT within the 1st month, 2nd -3rd months and 4th - 6th months postoperatively. Results: One-hundred sixty seven patients who underwent LDLT during the period from 2005 -2019 were included in this study. They were middle aged (mean age = 48.7±8.6) and mainly (92%) males. Mean preoperative ALBI was -1.24 ± 0.59. Two-thirds (67.1%) of the patients belonged to ALBI grade III. Within 6 months post LT, biliary complications were found to be the most common post LT (55.5% out of all complications), whereas mortality rate was 28.1%. ALBI score was significantly related to biliary stricture (P=0.041) within 6 months postoperatively, and nephrotoxicity and septicemia with high ALBI grades (II and III) within 1st month postoperatively (P = 0.007 and 0.024, respectively). However, it was not significantly related to post-LT mortality